Jacobs Levy Equity Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-509,225
| Closed | -$3.11M | – | 1143 |
|
|
2021
Q3 | $3.11M | Sell |
509,225
-385,389
| -43% | -$2.35M | 0.02% | 532 |
|
|
2021
Q2 | $7.36M | Buy |
894,614
+120,552
| +16% | +$992K | 0.05% | 359 |
|
|
2021
Q1 | $6.93M | Buy |
774,062
+428,656
| +124% | +$3.84M | 0.05% | 359 |
|
|
2020
Q4 | $3.99M | Buy |
+345,406
| New | +$3.99M | 0.04% | 437 |
|
|
2016
Q4 | – | Sell |
-18,400
| Closed | -$360K | – | 1093 |
|
|
2016
Q3 | $360K | Sell |
18,400
-10,400
| -36% | -$203K | 0.01% | 772 |
|
|
2016
Q2 | $431K | Sell |
28,800
-7,880
| -21% | -$118K | 0.01% | 794 |
|
|
2016
Q1 | $337K | Buy |
+36,680
| New | +$337K | 0.01% | 833 |
|
|
2015
Q3 | – | Sell |
-9,900
| Closed | -$217K | – | 882 |
|
|
2015
Q2 | $217K | Buy |
+9,900
| New | +$217K | ﹤0.01% | 715 |
|